Case Report
Published on 23 Oct 2023
Pembrolizumab combined with anlotinib improves therapeutic efficacy in pulmonary sarcomatoid carcinoma with TMB-H and PD-L1 expression: a case report and literature review
in Comparative Immunology
- 5,084 views
- 14 citations